Insulet Corporation

PODD · Healthcare

About Insulet Corporation

Insulet Corporation (PODD) has been publicly traded since 2007, making it a 19-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Acton, United States and employs approximately 5,400 people. With a market capitalization of $15 billion, PODD is a large established company.

Key Statistics

Current Price
$219.84
Market Cap
$15.48B
52-Week High
$354.88
52-Week Low
$216.51
Sector
Healthcare
Industry
Medical Devices

$1,000 Invested

1 Year
$899
+-10%
3 Years
$776
+-22%
5 Years
$888
+-11%
10 Years
$6,829
+583%
Since IPO
$13,774
+1277%

Monthly Returns Heatmap

Annual Returns

Avg Return
+21.03%
Best Year
2019 (+115.83%)
Worst Year
2008 (-67.12%)
Positive Years
14/19
Year Return Start End
2026 -22.66% $284.24 $219.84
2025 +8.88% $261.07 $284.24
2024 +20.32% $216.98 $261.07
2023 -26.30% $294.39 $216.98
2022 +10.64% $266.07 $294.39
2021 +4.08% $255.63 $266.07
2020 +49.32% $171.20 $255.63
2019 +115.83% $79.32 $171.20
2018 +14.96% $69.00 $79.32
2017 +83.12% $37.68 $69.00
2016 -0.34% $37.81 $37.68
2015 -17.91% $46.06 $37.81
2014 +24.15% $37.10 $46.06
2013 +74.84% $21.22 $37.10
2012 +12.69% $18.83 $21.22
2011 +21.48% $15.50 $18.83
2010 +8.54% $14.28 $15.50
2009 +84.97% $7.72 $14.28
2008 -67.12% $23.48 $7.72

Valuation

PODD currently trades at a trailing P/E ratio of 63.2, which is considered high relative to the broader market. The forward P/E of 27.2 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 10.2. The price-to-sales ratio is 5.7.

Dividends

Insulet Corporation does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.

Risk & Volatility

PODD has a beta of 1.44, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $216.49 to $354.88, and it currently trades near its 52-week low.

Analyst Ratings

Based on 25 analyst opinions, PODD has a consensus "strong_buy" rating. The average price target of $354.12 suggests 61.1% upside from current levels.

Frequently Asked Questions

What does Insulet Corporation do?

Insulet Corporation is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Acton, United States.

What sector is PODD in?

PODD operates in the Healthcare sector, specifically in the Medical Devices industry.

When did PODD go public?

Insulet Corporation went public in 2007, making it a 19-year-old public company as of 2026.

How much would $1,000 invested in PODD 5 years ago be worth today?

A $1,000 investment in PODD five years ago would be worth approximately $888 today, representing a -11.2% return.

Does PODD pay dividends?

No, Insulet Corporation does not currently pay a dividend. The company reinvests its earnings into growth.

What is PODD's market cap?

Insulet Corporation has a market capitalization of $15 billion, classifying it as a large-cap company.

What is PODD's P/E ratio?

PODD has a trailing P/E ratio of 63.2 and a forward P/E of 27.2, which measures how much investors are paying per dollar of earnings.

Is PODD a buy, hold, or sell?

Based on 25 opinions, PODD has a consensus "strong_buy" rating. The average price target is $354.12.

Last updated: 3/14/2026